(Q24243561)

PubMed

PubMed publication ID

17943912

30 October 2023

John KH Sinn

series ordinal

author given names

J K

author last names

Sinn

1 reference

PubMed

PubMed publication ID

17943912

Cochrane Database of Systematic Reviews

30 October 2023

language of work or name

1 reference

17 October 2007

0 references

published in

0 references

cites work

Safety of D(-)-lactic acid producing bacteria in the human infant

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Faecal SIgA secretion in infants fed on pre- or probiotic infant formula

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Probiotics in the management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Probiotic bacteria in the management of atopic disease: underscoring the importance of viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Probiotics: a novel approach in the management of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Lactobacillus paracasei A survives gastrointestinal passage and affects the fecal microbiota of healthy infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Evaluation of a diet containing probiotics and zinc for the treatment of mild diarrheal illness in children younger than one year of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Is the effect of probiotics on atopic dermatitis confined to food sensitized children?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Effects of probiotics on atopic dermatitis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Probiotics for treating infectious diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

World Allergy Organization guidelines for prevention of allergy and allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Allergy development and the intestinal microflora during the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Changes in asthma prevalence: two surveys 15 years apart

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Safety of probiotics: comparison of two popular strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Intestinal flora and mucosal immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Atopic versus infectious diseases in childhood: a question of balance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Maternal smoking in pregnancy, fetal development, and childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Fecal microbiota in sensitized wheezy and non-sensitized non-wheezy children: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Prebiotics in infants for prevention of allergic disease and food hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

The prevalence of food hypersensitivity in an unselected population of children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Low-normal gestational age as a predictor of asthma at 6 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

21 January 2018

Update on food allergy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

Atopic dermatitis: an increasing problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

[Evaluation of a formula with low protein content and supplemented with probiotic agents after breast milk weaning]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Effect of probiotic Lactobacillus strains in children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Probiotic intervention in the first months of life: short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Perinatal characteristics and obstetric complications as risk factors for asthma, allergy and eczema at the age of 6 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Evaluation of the effects of probiotic supplementation from the neonatal period on innate immune development in infancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Prediction of allergy from family history and cord blood IgE levels. A follow-up at the age of 5 years. Cord blood IgE. IV

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Effect of probiotics on vaccine antibody responses in infancy--a randomized placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Atopic disease in seven-year-old children. Incidence in relation to family history

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Specific probiotics in enhancing maturation of IgA responses in formula-fed infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021

The Australasian Society of Clinical Immunology and Allergy position statement: Summary of allergy prevention in children.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006475.PUB2

7 January 2021